About: Surveillance of the Middle East respiratory syndrome (MERS) coronavirus (CoV) infection in healthcare workers after contact with confirmed MERS patients: incidence and risk factors of MERS-CoV seropositivity

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Surveillance of the Middle East respiratory syndrome (MERS) coronavirus (CoV) infection in healthcare workers after contact with confirmed MERS patients: incidence and risk factors of MERS-CoV seropositivity Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Surveillance of the Middle East respiratory syndrome (MERS) coronavirus (CoV) infection in healthcare workers after contact with confirmed MERS patients: incidence and risk factors of MERS-CoV seropositivity
Creator	Lee, J Choi, Y Jung, Y Kim, H Kim, J Lee, H Lee, K Park, S Son, J Woo, H Yoon, J Bang, J Choi, H Choi, J Choi, J.-P Choi, S.-M Choi, S.-Y Choi, W Jang, H Jeong, S Kiem, S Kim, B.-N Kim, C.-J Kim, E Kim, K.-H Kim, N.-J Kim, Y.-S Oh, W Rhee, J Seol, H Wi, Y.-M
Source	Elsevier; Medline; PMC
abstract	Given the mode of transmission of Middle East respiratory syndrome (MERS), healthcare workers (HCWs) in contact with MERS patients are expected to be at risk of MERS infections. We evaluated the prevalence of MERS coronavirus (CoV) immunoglobulin (Ig) G in HCWs exposed to MERS patients and calculated the incidence of MERS-affected cases in HCWs. We enrolled HCWs from hospitals where confirmed MERS patients had visited. Serum was collected 4 to 6 weeks after the last contact with a confirmed MERS patient. We performed an enzyme-linked immunosorbent assay (ELISA) to screen for the presence of MERS-CoV IgG and an indirect immunofluorescence test (IIFT) to confirm MERS-CoV IgG. We used a questionnaire to collect information regarding the exposure. We calculated the incidence of MERS-affected cases by dividing the sum of PCR-confirmed and serology-confirmed cases by the number of exposed HCWs in participating hospitals. In total, 1169 HCWs in 31 hospitals had contact with 114 MERS patients, and among the HCWs, 15 were PCR-confirmed MERS cases in study hospitals. Serologic analysis was performed for 737 participants. ELISA was positive in five participants and borderline for seven. IIFT was positive for two (0.3%) of these 12 participants. Among the participants who did not use appropriate personal protective equipment (PPE), seropositivity was 0.7% (2/294) compared to 0% (0/443) in cases with appropriate PPE use. The incidence of MERS infection in HCWs was 1.5% (17/1169). The seroprevalence of MERS-CoV IgG among HCWs was higher among participants who did not use appropriate PPE.
has issue date	2016-07-27(xsd:dateTime)
bibo:doi	10.1016/j.cmi.2016.07.017
bibo:pmid	27475739
has license	no-cc
sha1sum (hex)	e846a66df38ee359002817baaea792a60ee05e75
schema:url	https://doi.org/10.1016/j.cmi.2016.07.017
resource representing a document's title	Surveillance of the Middle East respiratory syndrome (MERS) coronavirus (CoV) infection in healthcare workers after contact with confirmed MERS patients: incidence and risk factors of MERS-CoV seropositivity
has PubMed Central identifier	PMC7128923
has PubMed identifier	27475739
schema:publication	Clin Microbiol Infect
resource representing a document's body	covid:e846a66df38ee359002817baaea792a60ee05e75#body_text
is schema:about of	named entity 'CORONAVIRUS' named entity 'healthcare' named entity 'MERS-COV' named entity 'EDITOR' named entity 'PAUL' named entity 'SEROPOSITIVITY' named entity 'SURVEILLANCE' named entity 'CONFIRMED' named entity 'PATIENTS' covid:arg/e846a66df38ee359002817baaea792a60ee05e75 named entity 'MERS' named entity 'HEALTHCARE WORKERS' named entity 'CONTACT WITH' named entity 'INCIDENCE' named entity 'MIDDLE EAST RESPIRATORY SYNDROME ' named entity 'INFECTION' named entity 'RISK FACTORS' named entity 'infection' named entity 'MERS-CoV' named entity 'MERS' named entity 'PPE' named entity 'MERS' named entity 'epidemic' named entity 'seropositive' named entity 'PPE' named entity 'national guidelines' named entity 'MERS' named entity 'MERS-CoV' named entity 'coronavirus' named entity 'MERS' named entity 'MERS' named entity 'AGP' named entity 'asymptomatic' named entity 'SPSS' named entity 'PCR' named entity 'PAPR' named entity 'MERS' named entity 'MERS' named entity 'Lübeck' named entity 'doctors, nurses' named entity 'PPE' named entity 'South Korea' named entity 'infection' named entity 'N95 respirators' named entity 'IgG' named entity 'antibody' named entity 'PPE' named entity 'MERS' named entity 'MERS' named entity 'asymptomatic' named entity 'Oriental medicine'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software